Cargando…
Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management
Calcineurin inhibitors (CNI) are the mainstay of immunosuppressant medications in both bone marrow transplants and solid organ transplants. Nephrotoxicity is a well-known adverse effect of this group. Type IV renal tubular acidosis is a potentially under-recognized complication. Here we report a cas...
Autores principales: | AL-Omairi, Anwar, Abdulnasser Obaid, Mohammed, Agrawal, Indira, Abdalla, Amr, Al Rawas, Abdul Hakim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332329/ https://www.ncbi.nlm.nih.gov/pubmed/37435251 http://dx.doi.org/10.7759/cureus.40215 |
Ejemplares similares
-
Molecular Pathophysiology of Renal Tubular Acidosis
por: Pereira, P.C.B, et al.
Publicado: (2009) -
Tacrolimus-Induced Type IV Renal Tubular Acidosis following Liver Transplantation
por: Schmoyer, Christopher, et al.
Publicado: (2017) -
Flecainide toxicity in renal tubular acidosis type IV treated with extracorporeal membrane oxygenation
por: Bhimani, Salima Ahmed, et al.
Publicado: (2020) -
SUN-512 Graves’ Disease Induced Renal Tubular Acidosis
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020) -
Renal tubular acidosis with hyperchloremic acidosis: harmless with a sting?
por: Honore, Patrick M., et al.
Publicado: (2015)